CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $627,549
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$627,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-02-22 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +10,000 | $8.98 | $90K | 11,035,874 |
| 2008-02-04 | BARBIER REMI President and CEO | Sale | +25,000 | $8.93 | $223K | 7,091,200 |
| 2008-02-01 | BARBIER REMI President and CEO | Sale | −25,000 | $8.82 | $221K | 7,116,200 |
| 2008-01-30 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +37,056 | $8.95 | $332K | 11,025,874 |
| 2008-01-29 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +20,344 | $9.03 | $184K | 10,988,818 |
| 2008-01-22 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +17,325 | $8.89 | $154K | 10,968,474 |
| 2008-01-17 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +24,700 | $9.52 | $235K | 10,946,149 |
| 2008-01-17 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +5,000 | $9.49 | $47K | 10,951,149 |
| 2008-01-16 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +275 | $9.53 | $3K | 10,921,449 |
| 2008-01-15 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +8,550 | $9.63 | $82K | 10,921,174 |
| 2008-01-14 | EASTBOURNE CAPITAL MANAGEMENT LLC/CA 10% owner | Purchase | +11,450 | $9.75 | $112K | 10,912,624 |
| 2008-01-03 | BARBIER REMI President and CEO | Sale | −25,000 | $10.11 | $253K | 7,141,200 |
| 2008-01-02 | BARBIER REMI President and CEO | Sale | −25,000 | $10.27 | $257K | 7,166,200 |
| 2007-12-07 | BARBIER REMI President and CEO | Other acquisition · Common Stock | +20,000 | $10.53 | $211K | 154,700 |
| 2007-12-07 | FRIEDMANN NADAV Chief Operating & Med. Officer | Grant or award · Stock Options | +60,000 | $10.53 | $632K | 1,760,000 |
| 2007-12-04 | BARBIER REMI President and CEO | Sale | −25,000 | $10.08 | $252K | 7,191,200 |
| 2007-12-03 | BARBIER REMI President and CEO | Sale | −25,000 | $10.43 | $261K | 7,216,200 |
| 2007-11-02 | BARBIER REMI President and CEO | Sale | −25,000 | $11.08 | $277K | 7,241,200 |
| 2007-11-01 | RODDY PETER S Vice President and CFO | Purchase | +1,026 | $6.50 | $7K | 22,441 |
| 2007-11-01 | FRIEDMANN NADAV Chief Operating & Med. Officer | Purchase | +193 | $6.50 | $1K | 155,305 |
Page 36 of 38 · 751 trades